University at Buffalo (UB)
Updated October 10, 2014 This content is archived.
A firm spun off from the research led by Frederick Sachs, PhD, SUNY Distinguished Professor of physiology and biophysics, has sold the rights to a potential therapy for muscular dystrophy.